Literature DB >> 1924387

Specificity of the murine IgD receptor on T cells is for N-linked glycans on IgD molecules.

A R Amin1, S M Tamma, J D Oppenheim, F D Finkelman, C Kieda, R F Coico, G J Thorbecke.   

Abstract

IgD receptors on murine T cells have been reported in this issue [Tamma, S. M. L., Amin, A. R., Finkelman, F. D., Chen, Y.-W., Thorbecke, G. J. & Coico, R. F. (1991) Proc. Natl. Acad. Sci. USA 88, 9233-9237] to bind either the first or third constant region of the heavy-chain of IgD molecules--findings that could not be satisfactorily explained by IgD amino acid sequences. We now find that boiled IgD molecules or low-Mr fragments from protease-digested IgD still inhibit binding of IgD-coated erythrocytes to IgD receptors. This inhibitory activity can be absorbed with the murine IgD-binding lectin from Griffonia simplicifolia 1 (GS-1) immobilized on Sepharose. N-linked glycans, obtained from N-glycanase-treated IgD and purified by binding to GS-1-Sepharose, also inhibit rosette formation of T-helper cells bearing receptors for IgD with IgD- or mutant IgD-coated erythrocytes. Deglycosylated IgD, produced by treatment with N-glycanase, no longer binds to the lectin and fails to inhibit IgD rosetting. Binding of intact IgD to T cells is also competitively inhibited by N-acetylgalactosamine, galactose, N-acetylglucosamine, and neoglycoproteins containing these sugars. These results clearly show that N-linked glycans, present in both the first and third constant regions of the delta heavy-chain domains, are prerequisites for binding of IgD to IgD receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924387      PMCID: PMC52689          DOI: 10.1073/pnas.88.20.9238

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Characterization and regulation of T-cell IgD receptors and IgD-binding factor.

Authors:  A R Amin; R F Coico; G J Thorbecke
Journal:  Res Immunol       Date:  1990-01

Review 2.  Role of IgD and T delta cells in the regulation of the humoral immune response.

Authors:  R F Coico; G W Siskind; G J Thorbecke
Journal:  Immunol Rev       Date:  1988-10       Impact factor: 12.988

3.  The B-cell binding site on human immunoglobulin E.

Authors:  D Vercelli; B Helm; P Marsh; E Padlan; R S Geha; H Gould
Journal:  Nature       Date:  1989-04-20       Impact factor: 49.962

4.  A rapid one step purification procedure for murine IgD based on the specific affinity of Bandeiraea (Griffonia) simplicifolia-1 for N-linked carbohydrates on IgD.

Authors:  J D Oppenheim; A R Amin; G J Thorbecke
Journal:  J Immunol Methods       Date:  1990-07-03       Impact factor: 2.303

5.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

Authors:  M P Bevilacqua; S Stengelin; M A Gimbrone; B Seed
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

6.  Binding site for IgE of the human lymphocyte low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is confined to the domain homologous with animal lectins.

Authors:  B Bettler; R Maier; D Rüegg; H Hofstetter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  ELAM-1--dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA.

Authors:  J B Lowe; L M Stoolman; R P Nair; R D Larsen; T L Berhend; R M Marks
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

8.  IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines.

Authors:  R F Coico; S L Tamma; M Bessler; C F Wei; G J Thorbecke
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

9.  Role of carbohydrate in binding of IgG to the Fc receptor of neonatal rat enterocytes.

Authors:  J V Peppard; S M Hobbs; L E Jackson
Journal:  Mol Immunol       Date:  1989-05       Impact factor: 4.407

10.  Cloning of a lymphocyte homing receptor reveals a lectin domain.

Authors:  L A Lasky; M S Singer; T A Yednock; D Dowbenko; C Fennie; H Rodriguez; T Nguyen; S Stachel; S D Rosen
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

View more
  8 in total

1.  Molecular characterization of immunoglobulin D in mammals: immunoglobulin heavy constant delta genes in dogs, chimpanzees and four old world monkey species.

Authors:  Kenneth A Rogers; Jennifer P Richardson; Franco Scinicariello; Roberta Attanasio
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  In memorium G. Jeanette Thorbecke, 1929-2001.

Authors:  Vincent K Tsiagbe; Susan Zolla-Pazner; Richard Coico; Nicholas M Ponzio
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

3.  Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.

Authors:  J P Drenth; J Göertz; M R Daha; J W van der Meer
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

Review 4.  Immunoglobulin Glycosylation Effects in Allergy and Immunity.

Authors:  Alexandra Epp; Kathryn C Sullivan; Andrew B Herr; Richard T Strait
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

Review 5.  Role of protein glycosylation in immune regulation.

Authors:  E F Hounsell; M J Davies
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

6.  The absence of immunoglobulin D B cell receptor-mediated signals promotes the production of autoantibodies and exacerbates glomerulonephritis in murine lupus.

Authors:  L Guo; J Tian; Z Guo; B Zheng; S Han
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

7.  Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome.

Authors:  Jacob F de Wolff; Stephen J Dickinson; Alice C Smith; Karen Molyneux; John Feehally; Anna Simon; Jonathan Barratt
Journal:  Clin Exp Med       Date:  2009-06-20       Impact factor: 3.984

8.  The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding.

Authors:  Wai-Heng Lua; Wei-Li Ling; Joshua Yi Yeo; Jun-Jie Poh; David Philip Lane; Samuel Ken-En Gan
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.